453 related articles for article (PubMed ID: 11931626)
41. Comparative virtual and experimental high-throughput screening for glycogen synthase kinase-3beta inhibitors.
Polgár T; Baki A; Szendrei GI; Keseru GM
J Med Chem; 2005 Dec; 48(25):7946-59. PubMed ID: 16335919
[TBL] [Abstract][Full Text] [Related]
42. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
43. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Deniz U; Ozkirimli E; Ulgen KO
J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
[TBL] [Abstract][Full Text] [Related]
44. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
45. Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening.
Xia G; Xue M; Liu L; Yu J; Liu H; Li P; Wang J; Li Y; Xiong B; Shen J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5739-44. PubMed ID: 21873057
[TBL] [Abstract][Full Text] [Related]
46. Discovery of new selective human aldose reductase inhibitors through virtual screening multiple binding pocket conformations.
Wang L; Gu Q; Zheng X; Ye J; Liu Z; Li J; Hu X; Hagler A; Xu J
J Chem Inf Model; 2013 Sep; 53(9):2409-22. PubMed ID: 23901876
[TBL] [Abstract][Full Text] [Related]
47. Identification of novel mPGES-1 inhibitors through screening of a chemical library.
Park SJ; Han SG; Ahsan HM; Lee K; Lee JY; Shin JS; Lee KT; Kang NS; Yu YG
Bioorg Med Chem Lett; 2012 Dec; 22(24):7335-9. PubMed ID: 23147075
[TBL] [Abstract][Full Text] [Related]
48. Investigation of Classical Organic and Ionic Liquid Cosolvents for Early-Stage Screening in Fragment-Based Inhibitor Design with Unrelated Bacterial and Human Dihydrofolate Reductases.
Toulouse JL; Abraham SMJ; Kadnikova N; Bastien D; Gauchot V; Schmitzer AR; Pelletier JN
Assay Drug Dev Technol; 2017; 15(4):141-153. PubMed ID: 28426233
[TBL] [Abstract][Full Text] [Related]
49. Ensemble-Based Virtual Screening Led to the Discovery of New Classes of Potent Tyrosinase Inhibitors.
Choi J; Choi KE; Park SJ; Kim SY; Jee JG
J Chem Inf Model; 2016 Feb; 56(2):354-67. PubMed ID: 26750991
[TBL] [Abstract][Full Text] [Related]
50. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
[TBL] [Abstract][Full Text] [Related]
51. Structure-based virtual screening approach to the discovery of novel inhibitors of eyes absent 2 phosphatase with various metal chelating moieties.
Park H; Jung SK; Yu KR; Kim JH; Kim YS; Ko JH; Park BC; Kim SJ
Chem Biol Drug Des; 2011 Oct; 78(4):642-50. PubMed ID: 21777393
[TBL] [Abstract][Full Text] [Related]
52. Focused library with a core structure extracted from natural products and modified: application to phosphatase inhibitors and several biochemical findings.
Hirai G; Sodeoka M
Acc Chem Res; 2015 May; 48(5):1464-73. PubMed ID: 25894598
[TBL] [Abstract][Full Text] [Related]
53. Screening in a cell-based assay for inhibitors of microglial nitric oxide production reveals calmodulin-regulated protein kinases as potential drug discovery targets.
Mirzoeva S; Koppal T; Petrova TV; Lukas TJ; Watterson DM; Van Eldik LJ
Brain Res; 1999 Oct; 844(1-2):126-34. PubMed ID: 10536268
[TBL] [Abstract][Full Text] [Related]
54. Discovery of new inhibitors of Cdc25B dual specificity phosphatases by structure-based virtual screening.
Lavecchia A; Di Giovanni C; Pesapane A; Montuori N; Ragno P; Martucci NM; Masullo M; De Vendittis E; Novellino E
J Med Chem; 2012 May; 55(9):4142-58. PubMed ID: 22524450
[TBL] [Abstract][Full Text] [Related]
55. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening.
Boehm HJ; Boehringer M; Bur D; Gmuender H; Huber W; Klaus W; Kostrewa D; Kuehne H; Luebbers T; Meunier-Keller N; Mueller F
J Med Chem; 2000 Jul; 43(14):2664-74. PubMed ID: 10893304
[TBL] [Abstract][Full Text] [Related]
56. Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening.
Yin K; Zhao G; Xu C; Qiu X; Wen B; Sun H; Liu G; Liu Y; Zhao Q; Wei Q; Huang B; Yan G; Cao J
Parasit Vectors; 2019 Mar; 12(1):98. PubMed ID: 30867024
[TBL] [Abstract][Full Text] [Related]
57. Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening.
Jean Kumar VU; Poyraz Ö; Saxena S; Schnell R; Yogeeswari P; Schneider G; Sriram D
Bioorg Med Chem Lett; 2013 Mar; 23(5):1182-6. PubMed ID: 23391589
[TBL] [Abstract][Full Text] [Related]
58. Rational Discovery of Novel Squalene Synthase Inhibitors through Pharmacophore Modelling.
Chokshi AB; Chhabria MT; Desai PR
Curr Comput Aided Drug Des; 2018; 14(3):221-233. PubMed ID: 29732977
[TBL] [Abstract][Full Text] [Related]
59. Discovery of inhibitors to block interactions of HIV-1 integrase with human LEDGF/p75 via structure-based virtual screening and bioassays.
Hu G; Li X; Zhang X; Li Y; Ma L; Yang LM; Liu G; Li W; Huang J; Shen X; Hu L; Zheng YT; Tang Y
J Med Chem; 2012 Nov; 55(22):10108-17. PubMed ID: 23046280
[TBL] [Abstract][Full Text] [Related]
60. From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.
Zhu J; Huang JW; Tseng PH; Yang YT; Fowble J; Shiau CW; Shaw YJ; Kulp SK; Chen CS
Cancer Res; 2004 Jun; 64(12):4309-18. PubMed ID: 15205346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
